Los Angeles Capital Management LLC Ironwood Pharmaceuticals Inc Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 331,700 shares of IRWD stock, worth $563,890. This represents 0.01% of its overall portfolio holdings.
Number of Shares
331,700
Previous 12,172
2625.11%
Holding current value
$563,890
Previous $50,000
2838.0%
% of portfolio
0.01%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding IRWD
# of Institutions
235Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$38.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$37.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$27.9 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$19.9 Million0.13% of portfolio
-
State Street Corp Boston, MA9.92MShares$16.9 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $260M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...